Purdue's Sleep Aid Patents Are Obvious, Judge Rules

March 30, 2015

Law360, New York (March 30, 2015, 3:01 PM ET) -- A New Jersey federal judge on Friday found that Purdue Pharmaceutical Products LP’s three patents for sleep aid Intermezzo are invalid for obviousness, granting a win to Actavis Elizabeth LLC, Novel Laboratories Inc. and others whom Purdue sued over plans to market their own generic versions of the drug.

All Content © 2003‐2015, Portfolio Media, Inc.

Jake M. Holdreith

Partner

Member of Executive Board

Related Publications

Second Quarter
Generically Speaking: A Hatch-Waxman Litigation Bulletin
Oren Langer, Christopher Pinahs, Emily Tremblay, and Christine May
Second Quarter
ANDA Approvals
GENERICally Speaking Hatch Waxman Bulletin
Second Quarter
ANDA Litigation Settlements
GENERICally Speaking Hatch Waxman Bulletin
Second Quarter
Generic Launches
GENERICally Speaking Hatch Waxman Bulletin
Second Quarter
New ANDA Cases
GENERICally Speaking Hatch Waxman Bulletin
Back to Top